Perspective: the benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions
This perspective, brought to MedChemNet members by Future Medicinal Chemistry, discusses the development of in silico approaches and methods to utilize big data in small molecule development.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.